253 related articles for article (PubMed ID: 10090924)
21. Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoantibody-associated vasculitides potentially increases neutrophil adhesion and impairs migration.
Hu N; Westra J; Rutgers A; Doornbos-Van der Meer B; Huitema MG; Stegeman CA; Abdulahad WH; Satchell SC; Mathieson PW; Heeringa P; Kallenberg CG
Arthritis Res Ther; 2011; 13(6):R201. PubMed ID: 22152684
[TBL] [Abstract][Full Text] [Related]
22. Signalling by CXC-chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPgammaS binding induced by IL-8 and GROalpha.
Hall DA; Beresford IJ; Browning C; Giles H
Br J Pharmacol; 1999 Feb; 126(3):810-8. PubMed ID: 10188995
[TBL] [Abstract][Full Text] [Related]
23. Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2.
Doroshenko T; Chaly Y; Savitskiy V; Maslakova O; Portyanko A; Gorudko I; Voitenok NN
Blood; 2002 Oct; 100(7):2668-71. PubMed ID: 12239185
[TBL] [Abstract][Full Text] [Related]
24. Chemokine antagonists that discriminate between interleukin-8 receptors. Selective blockers of CXCR2.
Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
J Biol Chem; 1997 Jun; 272(26):16166-9. PubMed ID: 9195914
[TBL] [Abstract][Full Text] [Related]
25. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
[TBL] [Abstract][Full Text] [Related]
26. Differential calcium signaling in dairy cows with specific CXCR1 genotypes potentially related to interleukin-8 receptor functionality.
Rambeaud M; Pighetti GM
Immunogenetics; 2007 Jan; 59(1):53-8. PubMed ID: 17119953
[TBL] [Abstract][Full Text] [Related]
27. Expression of the chemokine receptors CXCR1 and CXCR2 on granulocytes in human endotoxemia and tuberculosis: involvement of the p38 mitogen-activated protein kinase pathway.
Juffermans NP; Dekkers PE; Peppelenbosch MP; Speelman P; van Deventer SJ; van Der Poll T
J Infect Dis; 2000 Sep; 182(3):888-94. PubMed ID: 10950785
[TBL] [Abstract][Full Text] [Related]
28. CD45 modulation of CXCR1 and CXCR2 in human polymorphonuclear leukocytes.
Mitchell GB; Khandaker MH; Rahimpour R; Xu L; Lazarovits AI; Pickering JG; Suria H; Madrenas J; Pomerantz DK; Feldman RD; Kelvin DJ
Eur J Immunol; 1999 May; 29(5):1467-76. PubMed ID: 10359100
[TBL] [Abstract][Full Text] [Related]
29. Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation.
Richardson RM; Marjoram RJ; Barak LS; Snyderman R
J Immunol; 2003 Mar; 170(6):2904-11. PubMed ID: 12626541
[TBL] [Abstract][Full Text] [Related]
30. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
[TBL] [Abstract][Full Text] [Related]
31. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.
Salcedo R; Resau JH; Halverson D; Hudson EA; Dambach M; Powell D; Wasserman K; Oppenheim JJ
FASEB J; 2000 Oct; 14(13):2055-64. PubMed ID: 11023990
[TBL] [Abstract][Full Text] [Related]
32. CXCR1 and CXCR2 activation and regulation. Role of aspartate 199 of the second extracellular loop of CXCR2 in CXCL8-mediated rapid receptor internalization.
Nasser MW; Raghuwanshi SK; Malloy KM; Gangavarapu P; Shim JY; Rajarathnam K; Richardson RM
J Biol Chem; 2007 Mar; 282(9):6906-15. PubMed ID: 17204468
[TBL] [Abstract][Full Text] [Related]
33. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration.
White JR; Lee JM; Young PR; Hertzberg RP; Jurewicz AJ; Chaikin MA; Widdowson K; Foley JJ; Martin LD; Griswold DE; Sarau HM
J Biol Chem; 1998 Apr; 273(17):10095-8. PubMed ID: 9553055
[TBL] [Abstract][Full Text] [Related]
34. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions.
Raghuwanshi SK; Su Y; Singh V; Haynes K; Richmond A; Richardson RM
J Immunol; 2012 Sep; 189(6):2824-32. PubMed ID: 22869904
[TBL] [Abstract][Full Text] [Related]
35. LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2.
Aul R; Patel S; Summerhill S; Kilty I; Plumb J; Singh D
Int Immunopharmacol; 2012 Jul; 13(3):225-31. PubMed ID: 22561413
[TBL] [Abstract][Full Text] [Related]
36. The chemokine receptors CXCR1 and CXCR2 regulate oral cancer cell behaviour.
Khurram SA; Bingle L; McCabe BM; Farthing PM; Whawell SA
J Oral Pathol Med; 2014 Oct; 43(9):667-74. PubMed ID: 24965032
[TBL] [Abstract][Full Text] [Related]
37. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes.
Bonecchi R; Facchetti F; Dusi S; Luini W; Lissandrini D; Simmelink M; Locati M; Bernasconi S; Allavena P; Brandt E; Rossi F; Mantovani A; Sozzani S
J Immunol; 2000 Apr; 164(7):3862-9. PubMed ID: 10725748
[TBL] [Abstract][Full Text] [Related]
38. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor.
Baly DL; Horuk R; Yansura DG; Simmons LC; Fairbrother WJ; Kotts C; Wirth CM; Gillece-Castro BL; Toy K; Hesselgesser J; Allison DE
J Immunol; 1998 Nov; 161(9):4944-9. PubMed ID: 9794430
[TBL] [Abstract][Full Text] [Related]
39. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM
J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
